Italfarmaco

This study looks at the long-term safety and effects of the drug Givinostat in people with Duchenne muscular dystrophy (DMD) who have already taken it in earlier studies. About 206 participants will take the drug and be monitored for side effects and how well the drug works over …

This study tests a new drug, givinostat, against the current standard treatment hydroxyurea in 220 adults with a high-risk form of polycythemia vera, a blood cancer that increases red blood cells. The goal is to see if givinostat better controls blood counts and spleen size witho…